Shailender Bhatia
University of Washington(US)Fred Hutch Cancer Center(US)
Publications by Year
Research Areas
Polyomavirus and related diseases, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Antenna Design and Analysis, Bacteriophages and microbial interactions
Most-Cited Works
- → Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer(2012)7,940 cited
- → Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab(2017)2,514 cited
- → Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma(2017)2,174 cited
- → PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma(2016)1,234 cited
- → Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial(2016)1,206 cited
- → Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology(2019)554 cited
- Treatment of metastatic melanoma: an overview.(2009)